TUNGSTEN WEST PLC

Regulatory Filings • Nov 7, 2025

National Storage Mechanism | Additional information

RNS Number : 5839G

Tungsten West PLC

07 November 2025

7 November 2025

Tungsten West Plc

("Tungsten West", the "Company" or the "Group")

Successful Processing Trial

Tungsten West (LON:TUN), the mining company focused on restarting production at the Hemerdon tungsten and tin mine ("Hemerdon" or the "Project") in Devon, UK, is pleased to report positive progress from the ongoing processing trial at Hemerdon.

The trial is being undertaken as part of a programme focused on testing and optimising the performance of key sections of the mineral processing facility. The programme forms part of the Company's approach to de-risking operations and gathering technical data essential for the planned restart of full-scale production.

As part of the trial programme, the Company has generated its first trial tungsten concentrate.

Jeff Court, CEO of Tungsten West, commented:

"The progress we are making in this processing trial is an important milestone in restarting operations at Hemerdon and provides confidence to our neighbours, the Environment Agency, our investors and off-takers that we are moving towards production. We have ensured that all activities throughout this trial have been conducted to high environmental and operational standards.

"As the need for a diversified source of tungsten intensifies, Hemerdon becomes an even more important strategic asset."

Tungsten West team at the Hemerdon Mineral Processing Facility with trial tungsten concentrate.

Ends

For further information, please contact:

Enquiries

Tungsten West Jeff Court Tel: +44 (0) 1752 278500	Strand Hanson (Nominated Adviser and Financial Adviser) James Spinney / James Dance / Abigail Wennington Tel: +44 (0) 207 409 3494
BlytheRay (Financial PR) Tim Blythe / Megan Ray Tel: +44(0) 20 7138 3204 Email:  [email protected] Hannam & Partners (Broker) Andrew Chubb / Matt Hasson / Jay Ashfield Tel: +44 (0)20 7907 8500

Follow us on X @TungstenWest

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCFFFFLLTLRIIE